Table 3 Rate of treatment-related adverse events
Adverse event | N= 45 |
|---|---|
Mielotoxicity | |
Grade 1-2, n (%) | 1(2) |
Grade 3-4, n (%) | 8(18) |
Nauseas/Vomiting | |
Grade 1-2, n (%) | 7(16) |
Grade 3-4, n (%) | 9(20) |
Hepatitis | |
Grade 1-2, n (%) | 2(4) |
Grade 3-4, n (%) | 3(7) |
Nephrotoxicity | |
Grade 1-2, n (%) | 1(2) |
Grade 3-4, n (%) | 2(4) |
Neuropathy | |
Grade 1-2, n (%) | 7(16) |
Grade 3-4, n (%) | 5(11) |
Asthenia | |
Grade 1-2, n (%) | 7(16) |
Grade 3-4, n (%) | 5(11) |
Diarrhea | |
Grade 1-2, n (%) | 3(7) |
Grade 3-4, n (%) | 2(4) |
Mucositis | |
Grade 1-2, n (%) | 2 (4) |
Grade 3-4, n (%) | 1 (2) |
Cardiotoxicity | |
Grade 1-2, n (%) | 1 (2) |
Grade 3-4, n (%) | 1 (2) |